
[ Fri, Dec 06th 2024 ]: The Motley Fool Canada
[ Fri, Dec 06th 2024 ]: 24/7 Wall St
[ Fri, Dec 06th 2024 ]: thenightly
[ Fri, Dec 06th 2024 ]: ABC
[ Fri, Dec 06th 2024 ]: USA Today
[ Fri, Dec 06th 2024 ]: Forbes
[ Fri, Dec 06th 2024 ]: The Motley Fool Canada
[ Fri, Dec 06th 2024 ]: Forbes
[ Fri, Dec 06th 2024 ]: 24/7 Wall St
[ Fri, Dec 06th 2024 ]: Business Insider
[ Fri, Dec 06th 2024 ]: FXStreet
[ Fri, Dec 06th 2024 ]: Kiplinger
[ Fri, Dec 06th 2024 ]: 24/7 Wall St
[ Fri, Dec 06th 2024 ]: The Globe and Mail
[ Fri, Dec 06th 2024 ]: Business Insider
[ Fri, Dec 06th 2024 ]: bnnbloomberg
[ Fri, Dec 06th 2024 ]: bnnbloomberg
[ Fri, Dec 06th 2024 ]: The Globe and Mail
[ Fri, Dec 06th 2024 ]: FTAdviser
[ Fri, Dec 06th 2024 ]: The Globe and Mail
[ Fri, Dec 06th 2024 ]: Morningstar
[ Fri, Dec 06th 2024 ]: FXStreet
[ Fri, Dec 06th 2024 ]: The Daily Telegraph
[ Fri, Dec 06th 2024 ]: MSN
[ Fri, Dec 06th 2024 ]: MSN
[ Fri, Dec 06th 2024 ]: Sky
[ Fri, Dec 06th 2024 ]: Zawya
[ Fri, Dec 06th 2024 ]: Morningstar
[ Fri, Dec 06th 2024 ]: Business Standard
[ Fri, Dec 06th 2024 ]: The Motley Fool
[ Fri, Dec 06th 2024 ]: MSN
[ Fri, Dec 06th 2024 ]: 24/7 Wall St
[ Fri, Dec 06th 2024 ]: Motley Fool Australia
[ Fri, Dec 06th 2024 ]: The Globe and Mail
[ Fri, Dec 06th 2024 ]: The Motley Fool
[ Fri, Dec 06th 2024 ]: MSN
[ Fri, Dec 06th 2024 ]: The Motley Fool
[ Fri, Dec 06th 2024 ]: The Motley Fool

[ Thu, Dec 05th 2024 ]: The Motley Fool
[ Thu, Dec 05th 2024 ]: marketindex
[ Thu, Dec 05th 2024 ]: The Motley Fool UK
[ Thu, Dec 05th 2024 ]: The Globe and Mail
[ Thu, Dec 05th 2024 ]: The Motley Fool
[ Thu, Dec 05th 2024 ]: Yahoo Finance
[ Thu, Dec 05th 2024 ]: AOL
[ Thu, Dec 05th 2024 ]: MSN
[ Thu, Dec 05th 2024 ]: MSN
[ Thu, Dec 05th 2024 ]: MSN
Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
However, Englander's interest isn't limited to tech stocks. The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall Street.
The article from The Motley Fool discusses billionaire investor Izzy Englander's recent investment in the obesity treatment sector. Englander, through his hedge fund Millennium Management, has been acquiring shares in companies like Eli Lilly and Novo Nordisk, which are at the forefront of developing and marketing weight-loss drugs such as Mounjaro and Wegovy. These drugs have shown significant promise in treating obesity, a condition affecting millions globally, and are expected to generate substantial revenue due to high demand. The article highlights the potential of these treatments to revolutionize obesity management, potentially leading to a multi-billion dollar market. Englander's investment reflects a broader trend among investors betting on the future of obesity treatments, driven by the drugs' efficacy and the growing prevalence of obesity-related health issues.
Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2024/12/06/billionaire-izzy-englander-buying-obesity-stock/ ]
Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2024/12/06/billionaire-izzy-englander-buying-obesity-stock/ ]
Similar Stocks and Investing Publications
[ Mon, Oct 19th 2009 ]: WOPRAI
[ Fri, Oct 16th 2009 ]: WOPRAI
[ Wed, Oct 14th 2009 ]: WOPRAI
[ Wed, Oct 14th 2009 ]: WOPRAI
[ Wed, Oct 14th 2009 ]: WOPRAI
[ Thu, Oct 08th 2009 ]: WOPRAI
[ Mon, Oct 05th 2009 ]: WOPRAI
[ Sun, Oct 04th 2009 ]: WOPRAI
[ Sun, Oct 04th 2009 ]: WOPRAI
[ Mon, Sep 28th 2009 ]: WOPRAI
[ Mon, Sep 21st 2009 ]: WOPRAI